Advanced search options

Advanced Search Options 🞨

Browse by author name (“Author name starts with…”).

Find ETDs with:

in
/  
in
/  
in
/  
in

Written in Published in Earliest date Latest date

Sorted by

Results per page:

Sorted by: relevance · author · university · dateNew search

You searched for subject:(Multiple Myeloma). Showing records 1 – 30 of 258 total matches.

[1] [2] [3] [4] [5] [6] [7] [8] [9]

Search Limiters

Last 2 Years | English Only

Degrees

Levels

Languages

Country

▼ Search Limiters


University of Sydney

1. Bryant, Christian Edward. Studies of Plasmacytoid Dendritic Cells in Multiple Myeloma .

Degree: 2016, University of Sydney

 Despite major advances in pharmacotherapy for Multiple Myeloma (MM) it remains incurable. Efforts are underway to develop novel therapeutics which direct the immune system to… (more)

Subjects/Keywords: plasmacytoid; dendritic cell; multiple myeloma

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Bryant, C. E. (2016). Studies of Plasmacytoid Dendritic Cells in Multiple Myeloma . (Thesis). University of Sydney. Retrieved from http://hdl.handle.net/2123/16440

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Bryant, Christian Edward. “Studies of Plasmacytoid Dendritic Cells in Multiple Myeloma .” 2016. Thesis, University of Sydney. Accessed September 26, 2020. http://hdl.handle.net/2123/16440.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Bryant, Christian Edward. “Studies of Plasmacytoid Dendritic Cells in Multiple Myeloma .” 2016. Web. 26 Sep 2020.

Vancouver:

Bryant CE. Studies of Plasmacytoid Dendritic Cells in Multiple Myeloma . [Internet] [Thesis]. University of Sydney; 2016. [cited 2020 Sep 26]. Available from: http://hdl.handle.net/2123/16440.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Bryant CE. Studies of Plasmacytoid Dendritic Cells in Multiple Myeloma . [Thesis]. University of Sydney; 2016. Available from: http://hdl.handle.net/2123/16440

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


University of Alberta

2. Toman, Inka. Silencing immunoglobulin gene enhancers as a potential treatment strategy for multiple myeloma.

Degree: MS, Department of Oncology, 2009, University of Alberta

Multiple myeloma is a bone marrow malignancy characterized by the presence of monoclonal plasma cells. In 50-75% of myeloma patients, chromosome translocations at the IgH… (more)

Subjects/Keywords: IgH enhancers; multiple myeloma; translocations

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Toman, I. (2009). Silencing immunoglobulin gene enhancers as a potential treatment strategy for multiple myeloma. (Masters Thesis). University of Alberta. Retrieved from https://era.library.ualberta.ca/files/8c97kr58t

Chicago Manual of Style (16th Edition):

Toman, Inka. “Silencing immunoglobulin gene enhancers as a potential treatment strategy for multiple myeloma.” 2009. Masters Thesis, University of Alberta. Accessed September 26, 2020. https://era.library.ualberta.ca/files/8c97kr58t.

MLA Handbook (7th Edition):

Toman, Inka. “Silencing immunoglobulin gene enhancers as a potential treatment strategy for multiple myeloma.” 2009. Web. 26 Sep 2020.

Vancouver:

Toman I. Silencing immunoglobulin gene enhancers as a potential treatment strategy for multiple myeloma. [Internet] [Masters thesis]. University of Alberta; 2009. [cited 2020 Sep 26]. Available from: https://era.library.ualberta.ca/files/8c97kr58t.

Council of Science Editors:

Toman I. Silencing immunoglobulin gene enhancers as a potential treatment strategy for multiple myeloma. [Masters Thesis]. University of Alberta; 2009. Available from: https://era.library.ualberta.ca/files/8c97kr58t


University of Debrecen

3. Issack, Sadam Mohamed. New Treatment Approaches Multiple Myeloma .

Degree: DE – Általános Orvostudományi Kar, University of Debrecen

 The thesis is on current treatment approach to multiple Myeloma.Though an incurable disease as of now, great leaps have been taken in Myeloma management. This… (more)

Subjects/Keywords: Multiple Myeloma

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Issack, S. M. (n.d.). New Treatment Approaches Multiple Myeloma . (Thesis). University of Debrecen. Retrieved from http://hdl.handle.net/2437/263196

Note: this citation may be lacking information needed for this citation format:
No year of publication.
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Issack, Sadam Mohamed. “New Treatment Approaches Multiple Myeloma .” Thesis, University of Debrecen. Accessed September 26, 2020. http://hdl.handle.net/2437/263196.

Note: this citation may be lacking information needed for this citation format:
No year of publication.
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Issack, Sadam Mohamed. “New Treatment Approaches Multiple Myeloma .” Web. 26 Sep 2020.

Note: this citation may be lacking information needed for this citation format:
No year of publication.

Vancouver:

Issack SM. New Treatment Approaches Multiple Myeloma . [Internet] [Thesis]. University of Debrecen; [cited 2020 Sep 26]. Available from: http://hdl.handle.net/2437/263196.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation
No year of publication.

Council of Science Editors:

Issack SM. New Treatment Approaches Multiple Myeloma . [Thesis]. University of Debrecen; Available from: http://hdl.handle.net/2437/263196

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation
No year of publication.


National University of Ireland – Galway

4. Glavey, Siobhan. Multiple myeloma: The role of glycosylation in disease development and progression.

Degree: 2017, National University of Ireland – Galway

Multiple myeloma (MM) is a clonal plasma cell disorder that is characterized by skeletal destruction, renal failure, anaemia and hypercalcaemia. MM cells are intimately associated… (more)

Subjects/Keywords: Multiple myeloma; Glycosylation; Sialylation; Medicine

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Glavey, S. (2017). Multiple myeloma: The role of glycosylation in disease development and progression. (Thesis). National University of Ireland – Galway. Retrieved from http://hdl.handle.net/10379/6910

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Glavey, Siobhan. “Multiple myeloma: The role of glycosylation in disease development and progression. ” 2017. Thesis, National University of Ireland – Galway. Accessed September 26, 2020. http://hdl.handle.net/10379/6910.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Glavey, Siobhan. “Multiple myeloma: The role of glycosylation in disease development and progression. ” 2017. Web. 26 Sep 2020.

Vancouver:

Glavey S. Multiple myeloma: The role of glycosylation in disease development and progression. [Internet] [Thesis]. National University of Ireland – Galway; 2017. [cited 2020 Sep 26]. Available from: http://hdl.handle.net/10379/6910.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Glavey S. Multiple myeloma: The role of glycosylation in disease development and progression. [Thesis]. National University of Ireland – Galway; 2017. Available from: http://hdl.handle.net/10379/6910

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


University of Melbourne

5. Fedele, Pasquale Luke. The role of transcription factors in multiple myeloma.

Degree: 2018, University of Melbourne

Multiple myeloma (MM) is an incurable cancer of antibody secreting plasma cells. Approximately 1700 people are diagnosed and 900 people die from MM in Australia… (more)

Subjects/Keywords: multiple myeloma; plasma cells

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Fedele, P. L. (2018). The role of transcription factors in multiple myeloma. (Doctoral Dissertation). University of Melbourne. Retrieved from http://hdl.handle.net/11343/218089

Chicago Manual of Style (16th Edition):

Fedele, Pasquale Luke. “The role of transcription factors in multiple myeloma.” 2018. Doctoral Dissertation, University of Melbourne. Accessed September 26, 2020. http://hdl.handle.net/11343/218089.

MLA Handbook (7th Edition):

Fedele, Pasquale Luke. “The role of transcription factors in multiple myeloma.” 2018. Web. 26 Sep 2020.

Vancouver:

Fedele PL. The role of transcription factors in multiple myeloma. [Internet] [Doctoral dissertation]. University of Melbourne; 2018. [cited 2020 Sep 26]. Available from: http://hdl.handle.net/11343/218089.

Council of Science Editors:

Fedele PL. The role of transcription factors in multiple myeloma. [Doctoral Dissertation]. University of Melbourne; 2018. Available from: http://hdl.handle.net/11343/218089


Aristotle University Of Thessaloniki (AUTH); Αριστοτέλειο Πανεπιστήμιο Θεσσαλονίκης (ΑΠΘ)

6. Hadjiaggelidou, Christina. Μελέτη της επίδρασης της λεναλιδομίδης και της μπορτεζομίμπης στα ρυθμιστικά Τ-λεμφοκύτταρα σε ασθενείς με πολλαπλούν μυέλωμα.

Degree: 2016, Aristotle University Of Thessaloniki (AUTH); Αριστοτέλειο Πανεπιστήμιο Θεσσαλονίκης (ΑΠΘ)

OBJECTIVE: Immune dysfunction is an important feature of Multiple Myeloma (MM) and has been associated with reduced survival. Studies have shown that T regulatory cells… (more)

Subjects/Keywords: Πολλαπλούν μυέλωμα; Multiple myeloma

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Hadjiaggelidou, C. (2016). Μελέτη της επίδρασης της λεναλιδομίδης και της μπορτεζομίμπης στα ρυθμιστικά Τ-λεμφοκύτταρα σε ασθενείς με πολλαπλούν μυέλωμα. (Thesis). Aristotle University Of Thessaloniki (AUTH); Αριστοτέλειο Πανεπιστήμιο Θεσσαλονίκης (ΑΠΘ). Retrieved from http://hdl.handle.net/10442/hedi/37895

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Hadjiaggelidou, Christina. “Μελέτη της επίδρασης της λεναλιδομίδης και της μπορτεζομίμπης στα ρυθμιστικά Τ-λεμφοκύτταρα σε ασθενείς με πολλαπλούν μυέλωμα.” 2016. Thesis, Aristotle University Of Thessaloniki (AUTH); Αριστοτέλειο Πανεπιστήμιο Θεσσαλονίκης (ΑΠΘ). Accessed September 26, 2020. http://hdl.handle.net/10442/hedi/37895.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Hadjiaggelidou, Christina. “Μελέτη της επίδρασης της λεναλιδομίδης και της μπορτεζομίμπης στα ρυθμιστικά Τ-λεμφοκύτταρα σε ασθενείς με πολλαπλούν μυέλωμα.” 2016. Web. 26 Sep 2020.

Vancouver:

Hadjiaggelidou C. Μελέτη της επίδρασης της λεναλιδομίδης και της μπορτεζομίμπης στα ρυθμιστικά Τ-λεμφοκύτταρα σε ασθενείς με πολλαπλούν μυέλωμα. [Internet] [Thesis]. Aristotle University Of Thessaloniki (AUTH); Αριστοτέλειο Πανεπιστήμιο Θεσσαλονίκης (ΑΠΘ); 2016. [cited 2020 Sep 26]. Available from: http://hdl.handle.net/10442/hedi/37895.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Hadjiaggelidou C. Μελέτη της επίδρασης της λεναλιδομίδης και της μπορτεζομίμπης στα ρυθμιστικά Τ-λεμφοκύτταρα σε ασθενείς με πολλαπλούν μυέλωμα. [Thesis]. Aristotle University Of Thessaloniki (AUTH); Αριστοτέλειο Πανεπιστήμιο Θεσσαλονίκης (ΑΠΘ); 2016. Available from: http://hdl.handle.net/10442/hedi/37895

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

7. Stampoulia-Stampoulieh, Danai. Κυτταρογενετική και μοριακή διερεύνηση ασθενών με πολλαπλούν μυέλωμα.

Degree: 2014, University of Thessaly (UTH); Πανεπιστήμιο Θεσσαλίας

Multiple Myeloma (MΜ) is a B-cell neoplasia characterized by the malignant proliferation of plasma cells in the bone marrow. The malignant plasma cells produce a… (more)

Subjects/Keywords: Πολλαπλούν μυέλωμα; Multiple myeloma

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Stampoulia-Stampoulieh, D. (2014). Κυτταρογενετική και μοριακή διερεύνηση ασθενών με πολλαπλούν μυέλωμα. (Thesis). University of Thessaly (UTH); Πανεπιστήμιο Θεσσαλίας. Retrieved from http://hdl.handle.net/10442/hedi/34904

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Stampoulia-Stampoulieh, Danai. “Κυτταρογενετική και μοριακή διερεύνηση ασθενών με πολλαπλούν μυέλωμα.” 2014. Thesis, University of Thessaly (UTH); Πανεπιστήμιο Θεσσαλίας. Accessed September 26, 2020. http://hdl.handle.net/10442/hedi/34904.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Stampoulia-Stampoulieh, Danai. “Κυτταρογενετική και μοριακή διερεύνηση ασθενών με πολλαπλούν μυέλωμα.” 2014. Web. 26 Sep 2020.

Vancouver:

Stampoulia-Stampoulieh D. Κυτταρογενετική και μοριακή διερεύνηση ασθενών με πολλαπλούν μυέλωμα. [Internet] [Thesis]. University of Thessaly (UTH); Πανεπιστήμιο Θεσσαλίας; 2014. [cited 2020 Sep 26]. Available from: http://hdl.handle.net/10442/hedi/34904.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Stampoulia-Stampoulieh D. Κυτταρογενετική και μοριακή διερεύνηση ασθενών με πολλαπλούν μυέλωμα. [Thesis]. University of Thessaly (UTH); Πανεπιστήμιο Θεσσαλίας; 2014. Available from: http://hdl.handle.net/10442/hedi/34904

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


Texas A&M University

8. Harshbarger, Wayne. X-Ray Crystal Structure of Human 20s Proteasome in Complex with Carfilzomib.

Degree: PhD, Chemistry, 2015, Texas A&M University

 20S proteasomes are large, multicatalytic N- terminal threonine proteases which are tasked with maintaining intracellular homeostasis by the breaking down of mis-folded, oxidized, or tagged… (more)

Subjects/Keywords: 20S Proteasome; carfilzomib; multiple myeloma; cellular regulation

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Harshbarger, W. (2015). X-Ray Crystal Structure of Human 20s Proteasome in Complex with Carfilzomib. (Doctoral Dissertation). Texas A&M University. Retrieved from http://hdl.handle.net/1969.1/155004

Chicago Manual of Style (16th Edition):

Harshbarger, Wayne. “X-Ray Crystal Structure of Human 20s Proteasome in Complex with Carfilzomib.” 2015. Doctoral Dissertation, Texas A&M University. Accessed September 26, 2020. http://hdl.handle.net/1969.1/155004.

MLA Handbook (7th Edition):

Harshbarger, Wayne. “X-Ray Crystal Structure of Human 20s Proteasome in Complex with Carfilzomib.” 2015. Web. 26 Sep 2020.

Vancouver:

Harshbarger W. X-Ray Crystal Structure of Human 20s Proteasome in Complex with Carfilzomib. [Internet] [Doctoral dissertation]. Texas A&M University; 2015. [cited 2020 Sep 26]. Available from: http://hdl.handle.net/1969.1/155004.

Council of Science Editors:

Harshbarger W. X-Ray Crystal Structure of Human 20s Proteasome in Complex with Carfilzomib. [Doctoral Dissertation]. Texas A&M University; 2015. Available from: http://hdl.handle.net/1969.1/155004


Boston University

9. Forouzan, Eli. A phase 1/2 study of ixazomib as a replacement for bortezomib or carfilzomib for multiple myeloma patients recently relapsed or refractory to their last combination regimen containing either bortezomib or carfilzomib.

Degree: MS, Medical Sciences, 2020, Boston University

 BACKGROUND: Multiple myeloma is a rare form of cancer that affects the proper function of plasma cells in the immune system. Patients experience symptoms ranging… (more)

Subjects/Keywords: Oncology; Clinical trial; Ixazomib; Multiple myeloma

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Forouzan, E. (2020). A phase 1/2 study of ixazomib as a replacement for bortezomib or carfilzomib for multiple myeloma patients recently relapsed or refractory to their last combination regimen containing either bortezomib or carfilzomib. (Masters Thesis). Boston University. Retrieved from http://hdl.handle.net/2144/41248

Chicago Manual of Style (16th Edition):

Forouzan, Eli. “A phase 1/2 study of ixazomib as a replacement for bortezomib or carfilzomib for multiple myeloma patients recently relapsed or refractory to their last combination regimen containing either bortezomib or carfilzomib.” 2020. Masters Thesis, Boston University. Accessed September 26, 2020. http://hdl.handle.net/2144/41248.

MLA Handbook (7th Edition):

Forouzan, Eli. “A phase 1/2 study of ixazomib as a replacement for bortezomib or carfilzomib for multiple myeloma patients recently relapsed or refractory to their last combination regimen containing either bortezomib or carfilzomib.” 2020. Web. 26 Sep 2020.

Vancouver:

Forouzan E. A phase 1/2 study of ixazomib as a replacement for bortezomib or carfilzomib for multiple myeloma patients recently relapsed or refractory to their last combination regimen containing either bortezomib or carfilzomib. [Internet] [Masters thesis]. Boston University; 2020. [cited 2020 Sep 26]. Available from: http://hdl.handle.net/2144/41248.

Council of Science Editors:

Forouzan E. A phase 1/2 study of ixazomib as a replacement for bortezomib or carfilzomib for multiple myeloma patients recently relapsed or refractory to their last combination regimen containing either bortezomib or carfilzomib. [Masters Thesis]. Boston University; 2020. Available from: http://hdl.handle.net/2144/41248

10. Mwaba, Florence. Characterization of multiple myeloma at the University Teaching Hospital(UTH),Lusaka.

Degree: 2015, University of Zimbabwe

 Context: Multiple myeloma (MM) is the second most common blood cancer after lymphomas, thereby accounting for 10% of all haematological malignancies. The incidence of MM… (more)

Subjects/Keywords: Multiple Myeloma; Blood Cancer-Lusaka,Zambia

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Mwaba, F. (2015). Characterization of multiple myeloma at the University Teaching Hospital(UTH),Lusaka. (Thesis). University of Zimbabwe. Retrieved from http://dspace.unza.zm/handle/123456789/4231

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Mwaba, Florence. “Characterization of multiple myeloma at the University Teaching Hospital(UTH),Lusaka.” 2015. Thesis, University of Zimbabwe. Accessed September 26, 2020. http://dspace.unza.zm/handle/123456789/4231.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Mwaba, Florence. “Characterization of multiple myeloma at the University Teaching Hospital(UTH),Lusaka.” 2015. Web. 26 Sep 2020.

Vancouver:

Mwaba F. Characterization of multiple myeloma at the University Teaching Hospital(UTH),Lusaka. [Internet] [Thesis]. University of Zimbabwe; 2015. [cited 2020 Sep 26]. Available from: http://dspace.unza.zm/handle/123456789/4231.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Mwaba F. Characterization of multiple myeloma at the University Teaching Hospital(UTH),Lusaka. [Thesis]. University of Zimbabwe; 2015. Available from: http://dspace.unza.zm/handle/123456789/4231

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


Univerzitet u Beogradu

11. Sretenović, Aleksandra M., 1977-. Molekularno-genetički mehanizmi rezistencije u prognozi bolesnika sa multiplim mijelomom.

Degree: Medicinski fakultet, 2019, Univerzitet u Beogradu

Medicina - Hematologija / Medicine - Hematology

Multipli mijelom (MM) je bolest za koju se vezuje visok stepen genomske nestabilnosti. Karakteriše se numeričkim i strukturnim… (more)

Subjects/Keywords: multiple myeloma; molecular-genetic profile; prognosis

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Sretenović, Aleksandra M., 1. (2019). Molekularno-genetički mehanizmi rezistencije u prognozi bolesnika sa multiplim mijelomom. (Thesis). Univerzitet u Beogradu. Retrieved from https://fedorabg.bg.ac.rs/fedora/get/o:19365/bdef:Content/get

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Sretenović, Aleksandra M., 1977-. “Molekularno-genetički mehanizmi rezistencije u prognozi bolesnika sa multiplim mijelomom.” 2019. Thesis, Univerzitet u Beogradu. Accessed September 26, 2020. https://fedorabg.bg.ac.rs/fedora/get/o:19365/bdef:Content/get.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Sretenović, Aleksandra M., 1977-. “Molekularno-genetički mehanizmi rezistencije u prognozi bolesnika sa multiplim mijelomom.” 2019. Web. 26 Sep 2020.

Vancouver:

Sretenović, Aleksandra M. 1. Molekularno-genetički mehanizmi rezistencije u prognozi bolesnika sa multiplim mijelomom. [Internet] [Thesis]. Univerzitet u Beogradu; 2019. [cited 2020 Sep 26]. Available from: https://fedorabg.bg.ac.rs/fedora/get/o:19365/bdef:Content/get.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Sretenović, Aleksandra M. 1. Molekularno-genetički mehanizmi rezistencije u prognozi bolesnika sa multiplim mijelomom. [Thesis]. Univerzitet u Beogradu; 2019. Available from: https://fedorabg.bg.ac.rs/fedora/get/o:19365/bdef:Content/get

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

12. Friend, Natasha Lauren. The Role of SAMSN1 in Multiple Myeloma.

Degree: 2019, University of Adelaide

Multiple myeloma (MM) is a haematological malignancy characterised by the uncontrolled clonal proliferation of neoplastic plasma cells (PCs) within the bone marrow (BM). Our group… (more)

Subjects/Keywords: SAMSN1; GLIPR1; multiple myeloma; genetics; KaLwRij

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Friend, N. L. (2019). The Role of SAMSN1 in Multiple Myeloma. (Thesis). University of Adelaide. Retrieved from http://hdl.handle.net/2440/121339

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Friend, Natasha Lauren. “The Role of SAMSN1 in Multiple Myeloma.” 2019. Thesis, University of Adelaide. Accessed September 26, 2020. http://hdl.handle.net/2440/121339.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Friend, Natasha Lauren. “The Role of SAMSN1 in Multiple Myeloma.” 2019. Web. 26 Sep 2020.

Vancouver:

Friend NL. The Role of SAMSN1 in Multiple Myeloma. [Internet] [Thesis]. University of Adelaide; 2019. [cited 2020 Sep 26]. Available from: http://hdl.handle.net/2440/121339.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Friend NL. The Role of SAMSN1 in Multiple Myeloma. [Thesis]. University of Adelaide; 2019. Available from: http://hdl.handle.net/2440/121339

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


University of Minnesota

13. Reule, Scott. End Stage Renal Disease due to Multiple Myeloma in the United States, 2001-2010.

Degree: MS, Clinical Research, 2017, University of Minnesota

 Abstract. While the management of myeloma and light chain deposition disease (“MM”) has changed considerably in the last decade, it is unknown how the burden… (more)

Subjects/Keywords: Dialysis; Incidence; Kidney transplantation; Multiple Myeloma

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Reule, S. (2017). End Stage Renal Disease due to Multiple Myeloma in the United States, 2001-2010. (Masters Thesis). University of Minnesota. Retrieved from http://hdl.handle.net/11299/194642

Chicago Manual of Style (16th Edition):

Reule, Scott. “End Stage Renal Disease due to Multiple Myeloma in the United States, 2001-2010.” 2017. Masters Thesis, University of Minnesota. Accessed September 26, 2020. http://hdl.handle.net/11299/194642.

MLA Handbook (7th Edition):

Reule, Scott. “End Stage Renal Disease due to Multiple Myeloma in the United States, 2001-2010.” 2017. Web. 26 Sep 2020.

Vancouver:

Reule S. End Stage Renal Disease due to Multiple Myeloma in the United States, 2001-2010. [Internet] [Masters thesis]. University of Minnesota; 2017. [cited 2020 Sep 26]. Available from: http://hdl.handle.net/11299/194642.

Council of Science Editors:

Reule S. End Stage Renal Disease due to Multiple Myeloma in the United States, 2001-2010. [Masters Thesis]. University of Minnesota; 2017. Available from: http://hdl.handle.net/11299/194642


Boston University

14. Lee, Saem. Efficacy and safety of bortezomib with dexamethasone regimen in elderly newly diagnosed multiple myeloma patients with co-morbidities.

Degree: MS, Medical Sciences, 2014, Boston University

 Bortezomib-based induction therapies have shown to increase complete response rates and are used as an upfront therapy for newly diagnosed multiple myeloma patients. The standard… (more)

Subjects/Keywords: Oncology; Bortezomib; Multiple myeloma; Newly diagnosed

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Lee, S. (2014). Efficacy and safety of bortezomib with dexamethasone regimen in elderly newly diagnosed multiple myeloma patients with co-morbidities. (Masters Thesis). Boston University. Retrieved from http://hdl.handle.net/2144/14373

Chicago Manual of Style (16th Edition):

Lee, Saem. “Efficacy and safety of bortezomib with dexamethasone regimen in elderly newly diagnosed multiple myeloma patients with co-morbidities.” 2014. Masters Thesis, Boston University. Accessed September 26, 2020. http://hdl.handle.net/2144/14373.

MLA Handbook (7th Edition):

Lee, Saem. “Efficacy and safety of bortezomib with dexamethasone regimen in elderly newly diagnosed multiple myeloma patients with co-morbidities.” 2014. Web. 26 Sep 2020.

Vancouver:

Lee S. Efficacy and safety of bortezomib with dexamethasone regimen in elderly newly diagnosed multiple myeloma patients with co-morbidities. [Internet] [Masters thesis]. Boston University; 2014. [cited 2020 Sep 26]. Available from: http://hdl.handle.net/2144/14373.

Council of Science Editors:

Lee S. Efficacy and safety of bortezomib with dexamethasone regimen in elderly newly diagnosed multiple myeloma patients with co-morbidities. [Masters Thesis]. Boston University; 2014. Available from: http://hdl.handle.net/2144/14373


University of Melbourne

15. Wong Doo, Nicole. DNA methylation marks in peripheral blood and the risk of developing mature B cell neoplasms.

Degree: 2018, University of Melbourne

 Dysregulation of DNA methylation is a feature of mature B cell neoplasms (MBCN) but it is not known whether methylation changes can be detected in… (more)

Subjects/Keywords: DNA methylation; lymphoma; multiple myeloma; Eepigenetics; epigenomics

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Wong Doo, N. (2018). DNA methylation marks in peripheral blood and the risk of developing mature B cell neoplasms. (Doctoral Dissertation). University of Melbourne. Retrieved from http://hdl.handle.net/11343/220501

Chicago Manual of Style (16th Edition):

Wong Doo, Nicole. “DNA methylation marks in peripheral blood and the risk of developing mature B cell neoplasms.” 2018. Doctoral Dissertation, University of Melbourne. Accessed September 26, 2020. http://hdl.handle.net/11343/220501.

MLA Handbook (7th Edition):

Wong Doo, Nicole. “DNA methylation marks in peripheral blood and the risk of developing mature B cell neoplasms.” 2018. Web. 26 Sep 2020.

Vancouver:

Wong Doo N. DNA methylation marks in peripheral blood and the risk of developing mature B cell neoplasms. [Internet] [Doctoral dissertation]. University of Melbourne; 2018. [cited 2020 Sep 26]. Available from: http://hdl.handle.net/11343/220501.

Council of Science Editors:

Wong Doo N. DNA methylation marks in peripheral blood and the risk of developing mature B cell neoplasms. [Doctoral Dissertation]. University of Melbourne; 2018. Available from: http://hdl.handle.net/11343/220501


University of Adelaide

16. Zeissig, Mara Natasha. CCR1 as a therapeutic target in multiple myeloma: preventing tumour dissemination and therapeutic resistance.

Degree: 2020, University of Adelaide

Multiple myeloma (MM) is a haematological malignancy characterised by the clonal proliferation of plasma cells (PC) within the bone marrow (BM). While the introduction of… (more)

Subjects/Keywords: multiple myeloma; dissemination; chemokine receptors; CCR1; CCR10

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Zeissig, M. N. (2020). CCR1 as a therapeutic target in multiple myeloma: preventing tumour dissemination and therapeutic resistance. (Thesis). University of Adelaide. Retrieved from http://hdl.handle.net/2440/127297

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Zeissig, Mara Natasha. “CCR1 as a therapeutic target in multiple myeloma: preventing tumour dissemination and therapeutic resistance.” 2020. Thesis, University of Adelaide. Accessed September 26, 2020. http://hdl.handle.net/2440/127297.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Zeissig, Mara Natasha. “CCR1 as a therapeutic target in multiple myeloma: preventing tumour dissemination and therapeutic resistance.” 2020. Web. 26 Sep 2020.

Vancouver:

Zeissig MN. CCR1 as a therapeutic target in multiple myeloma: preventing tumour dissemination and therapeutic resistance. [Internet] [Thesis]. University of Adelaide; 2020. [cited 2020 Sep 26]. Available from: http://hdl.handle.net/2440/127297.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Zeissig MN. CCR1 as a therapeutic target in multiple myeloma: preventing tumour dissemination and therapeutic resistance. [Thesis]. University of Adelaide; 2020. Available from: http://hdl.handle.net/2440/127297

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


Freie Universität Berlin

17. Kunz, Katharina. Bedeutung der Durchflusszytometrie im Kontext der Diagnostik des Multiplen Myeloms.

Degree: 2020, Freie Universität Berlin

 Background: Multiple Myeloma (MM) accounts for 10% of all malignant hematological disorders. While the estimation of plasma cell infiltration in bone marrow biopsy as well… (more)

Subjects/Keywords: multiple myeloma; flow cytometry; immunphenotype; ddc:610

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Kunz, K. (2020). Bedeutung der Durchflusszytometrie im Kontext der Diagnostik des Multiplen Myeloms. (Thesis). Freie Universität Berlin. Retrieved from http://dx.doi.org/10.17169/refubium-27328

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Kunz, Katharina. “Bedeutung der Durchflusszytometrie im Kontext der Diagnostik des Multiplen Myeloms.” 2020. Thesis, Freie Universität Berlin. Accessed September 26, 2020. http://dx.doi.org/10.17169/refubium-27328.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Kunz, Katharina. “Bedeutung der Durchflusszytometrie im Kontext der Diagnostik des Multiplen Myeloms.” 2020. Web. 26 Sep 2020.

Vancouver:

Kunz K. Bedeutung der Durchflusszytometrie im Kontext der Diagnostik des Multiplen Myeloms. [Internet] [Thesis]. Freie Universität Berlin; 2020. [cited 2020 Sep 26]. Available from: http://dx.doi.org/10.17169/refubium-27328.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Kunz K. Bedeutung der Durchflusszytometrie im Kontext der Diagnostik des Multiplen Myeloms. [Thesis]. Freie Universität Berlin; 2020. Available from: http://dx.doi.org/10.17169/refubium-27328

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

18. Kassambara, Alboukadel. Identification de nouveaux biomarqueurs pronostiques dans le myélome multiple et évaluation du rôle biologique : Identification of new prognostic biomarkers in multiple myeloma and evaluation of their biological function.

Degree: Docteur es, Biologie Santé, 2011, Université Montpellier I

Le myélome multiple (MM) est une néoplasie B caractérisée par l'accumulation d'un clone plasmocytaire dans la moelle osseuse. Cette pathologie demeure incurable d'où la nécessité… (more)

Subjects/Keywords: Myélome multiple; Pronostic; Microenvironnement; Multiple myeloma; Prognosis; Microenvironment

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Kassambara, A. (2011). Identification de nouveaux biomarqueurs pronostiques dans le myélome multiple et évaluation du rôle biologique : Identification of new prognostic biomarkers in multiple myeloma and evaluation of their biological function. (Doctoral Dissertation). Université Montpellier I. Retrieved from http://www.theses.fr/2011MON13508

Chicago Manual of Style (16th Edition):

Kassambara, Alboukadel. “Identification de nouveaux biomarqueurs pronostiques dans le myélome multiple et évaluation du rôle biologique : Identification of new prognostic biomarkers in multiple myeloma and evaluation of their biological function.” 2011. Doctoral Dissertation, Université Montpellier I. Accessed September 26, 2020. http://www.theses.fr/2011MON13508.

MLA Handbook (7th Edition):

Kassambara, Alboukadel. “Identification de nouveaux biomarqueurs pronostiques dans le myélome multiple et évaluation du rôle biologique : Identification of new prognostic biomarkers in multiple myeloma and evaluation of their biological function.” 2011. Web. 26 Sep 2020.

Vancouver:

Kassambara A. Identification de nouveaux biomarqueurs pronostiques dans le myélome multiple et évaluation du rôle biologique : Identification of new prognostic biomarkers in multiple myeloma and evaluation of their biological function. [Internet] [Doctoral dissertation]. Université Montpellier I; 2011. [cited 2020 Sep 26]. Available from: http://www.theses.fr/2011MON13508.

Council of Science Editors:

Kassambara A. Identification de nouveaux biomarqueurs pronostiques dans le myélome multiple et évaluation du rôle biologique : Identification of new prognostic biomarkers in multiple myeloma and evaluation of their biological function. [Doctoral Dissertation]. Université Montpellier I; 2011. Available from: http://www.theses.fr/2011MON13508

19. Schoenhals, Matthieu. Gènes reprogrammant des cellules adultes en cellules souches pluripotentes : expression et implication dans les cancers plasmocytaires humains. : Genes that reprogram adult cells to pluripotent stem cells : expression and implications in human plasma cell cancers.

Degree: Docteur es, Biologie Santé, 2011, Université Montpellier I

Le myélome multiple (MM) est une néoplasie lymphocytaire B qui se caractérise par l'accumulation d'un clone de cellules plasmocytaires tumorales dans la moelle osseuse interagissant… (more)

Subjects/Keywords: Myelome Multiple; Klf4; Pluripotence; Multiple Myeloma; Klf4; Pluripotency

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Schoenhals, M. (2011). Gènes reprogrammant des cellules adultes en cellules souches pluripotentes : expression et implication dans les cancers plasmocytaires humains. : Genes that reprogram adult cells to pluripotent stem cells : expression and implications in human plasma cell cancers. (Doctoral Dissertation). Université Montpellier I. Retrieved from http://www.theses.fr/2011MON1T025

Chicago Manual of Style (16th Edition):

Schoenhals, Matthieu. “Gènes reprogrammant des cellules adultes en cellules souches pluripotentes : expression et implication dans les cancers plasmocytaires humains. : Genes that reprogram adult cells to pluripotent stem cells : expression and implications in human plasma cell cancers.” 2011. Doctoral Dissertation, Université Montpellier I. Accessed September 26, 2020. http://www.theses.fr/2011MON1T025.

MLA Handbook (7th Edition):

Schoenhals, Matthieu. “Gènes reprogrammant des cellules adultes en cellules souches pluripotentes : expression et implication dans les cancers plasmocytaires humains. : Genes that reprogram adult cells to pluripotent stem cells : expression and implications in human plasma cell cancers.” 2011. Web. 26 Sep 2020.

Vancouver:

Schoenhals M. Gènes reprogrammant des cellules adultes en cellules souches pluripotentes : expression et implication dans les cancers plasmocytaires humains. : Genes that reprogram adult cells to pluripotent stem cells : expression and implications in human plasma cell cancers. [Internet] [Doctoral dissertation]. Université Montpellier I; 2011. [cited 2020 Sep 26]. Available from: http://www.theses.fr/2011MON1T025.

Council of Science Editors:

Schoenhals M. Gènes reprogrammant des cellules adultes en cellules souches pluripotentes : expression et implication dans les cancers plasmocytaires humains. : Genes that reprogram adult cells to pluripotent stem cells : expression and implications in human plasma cell cancers. [Doctoral Dissertation]. Université Montpellier I; 2011. Available from: http://www.theses.fr/2011MON1T025

20. Alaterre, Elina. Identification fine des cellules plasmocytaires normales et tumorales dans la moelle osseuse de patients atteints de myélome multiple en cytométrie en flux : Normal and tumoral plasma cells accurate identification in bone marrow of multiple myeloma patients using flow cytometry.

Degree: Docteur es, Biologie Santé, 2017, Montpellier

Le myélome multiple (MM) est une hémopathie maligne caractérisée par la prolifération d’un clone plasmocytaire tumoral dans la moelle osseuse et d’une accumulation d’une immunoglobuline… (more)

Subjects/Keywords: Immuno-phénotypage; Cytométrie en flux; Plasmocytes; Multiple myeloma; Maladie résiuelle; Immunophenotyping; Flow cytometry; Plasma cells; Multiple myeloma; Residual disease

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Alaterre, E. (2017). Identification fine des cellules plasmocytaires normales et tumorales dans la moelle osseuse de patients atteints de myélome multiple en cytométrie en flux : Normal and tumoral plasma cells accurate identification in bone marrow of multiple myeloma patients using flow cytometry. (Doctoral Dissertation). Montpellier. Retrieved from http://www.theses.fr/2017MONTT010

Chicago Manual of Style (16th Edition):

Alaterre, Elina. “Identification fine des cellules plasmocytaires normales et tumorales dans la moelle osseuse de patients atteints de myélome multiple en cytométrie en flux : Normal and tumoral plasma cells accurate identification in bone marrow of multiple myeloma patients using flow cytometry.” 2017. Doctoral Dissertation, Montpellier. Accessed September 26, 2020. http://www.theses.fr/2017MONTT010.

MLA Handbook (7th Edition):

Alaterre, Elina. “Identification fine des cellules plasmocytaires normales et tumorales dans la moelle osseuse de patients atteints de myélome multiple en cytométrie en flux : Normal and tumoral plasma cells accurate identification in bone marrow of multiple myeloma patients using flow cytometry.” 2017. Web. 26 Sep 2020.

Vancouver:

Alaterre E. Identification fine des cellules plasmocytaires normales et tumorales dans la moelle osseuse de patients atteints de myélome multiple en cytométrie en flux : Normal and tumoral plasma cells accurate identification in bone marrow of multiple myeloma patients using flow cytometry. [Internet] [Doctoral dissertation]. Montpellier; 2017. [cited 2020 Sep 26]. Available from: http://www.theses.fr/2017MONTT010.

Council of Science Editors:

Alaterre E. Identification fine des cellules plasmocytaires normales et tumorales dans la moelle osseuse de patients atteints de myélome multiple en cytométrie en flux : Normal and tumoral plasma cells accurate identification in bone marrow of multiple myeloma patients using flow cytometry. [Doctoral Dissertation]. Montpellier; 2017. Available from: http://www.theses.fr/2017MONTT010


University of Hong Kong

21. Fok, Wing-shan, Elaine. The pathogenetic role of pin1 in multiple myeloma.

Degree: 2007, University of Hong Kong

Subjects/Keywords: Multiple myeloma - Genetic aspects.

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Fok, Wing-shan, E. (2007). The pathogenetic role of pin1 in multiple myeloma. (Thesis). University of Hong Kong. Retrieved from http://hdl.handle.net/10722/131695

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Fok, Wing-shan, Elaine. “The pathogenetic role of pin1 in multiple myeloma.” 2007. Thesis, University of Hong Kong. Accessed September 26, 2020. http://hdl.handle.net/10722/131695.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Fok, Wing-shan, Elaine. “The pathogenetic role of pin1 in multiple myeloma.” 2007. Web. 26 Sep 2020.

Vancouver:

Fok, Wing-shan E. The pathogenetic role of pin1 in multiple myeloma. [Internet] [Thesis]. University of Hong Kong; 2007. [cited 2020 Sep 26]. Available from: http://hdl.handle.net/10722/131695.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Fok, Wing-shan E. The pathogenetic role of pin1 in multiple myeloma. [Thesis]. University of Hong Kong; 2007. Available from: http://hdl.handle.net/10722/131695

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


University of Hong Kong

22. Sin, Lai-fan. Characterization of genetic alterations in multiple myeloma: conventional and molecular cytogeneticsstudies.

Degree: 2011, University of Hong Kong

Subjects/Keywords: Multiple myeloma - Genetic aspects.

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Sin, L. (2011). Characterization of genetic alterations in multiple myeloma: conventional and molecular cytogeneticsstudies. (Thesis). University of Hong Kong. Retrieved from http://hdl.handle.net/10722/143166

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Sin, Lai-fan. “Characterization of genetic alterations in multiple myeloma: conventional and molecular cytogeneticsstudies.” 2011. Thesis, University of Hong Kong. Accessed September 26, 2020. http://hdl.handle.net/10722/143166.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Sin, Lai-fan. “Characterization of genetic alterations in multiple myeloma: conventional and molecular cytogeneticsstudies.” 2011. Web. 26 Sep 2020.

Vancouver:

Sin L. Characterization of genetic alterations in multiple myeloma: conventional and molecular cytogeneticsstudies. [Internet] [Thesis]. University of Hong Kong; 2011. [cited 2020 Sep 26]. Available from: http://hdl.handle.net/10722/143166.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Sin L. Characterization of genetic alterations in multiple myeloma: conventional and molecular cytogeneticsstudies. [Thesis]. University of Hong Kong; 2011. Available from: http://hdl.handle.net/10722/143166

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

23. Biswas, Sunetra. PERSISTENCE OF EBV IN THE CANCER STEM CELL FRACTION OF MULTIPLE MYELOMA.

Degree: 2013, Johns Hopkins University

 Epstein Barr Virus (EBV) is a human herpesvirus that infects most of the world’s adult population. It is associated with several malignancies including Burkitt lymphoma… (more)

Subjects/Keywords: multiple myeloma cancer stem cells; Epstein-Barr virus

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Biswas, S. (2013). PERSISTENCE OF EBV IN THE CANCER STEM CELL FRACTION OF MULTIPLE MYELOMA. (Thesis). Johns Hopkins University. Retrieved from http://jhir.library.jhu.edu/handle/1774.2/36974

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Biswas, Sunetra. “PERSISTENCE OF EBV IN THE CANCER STEM CELL FRACTION OF MULTIPLE MYELOMA.” 2013. Thesis, Johns Hopkins University. Accessed September 26, 2020. http://jhir.library.jhu.edu/handle/1774.2/36974.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Biswas, Sunetra. “PERSISTENCE OF EBV IN THE CANCER STEM CELL FRACTION OF MULTIPLE MYELOMA.” 2013. Web. 26 Sep 2020.

Vancouver:

Biswas S. PERSISTENCE OF EBV IN THE CANCER STEM CELL FRACTION OF MULTIPLE MYELOMA. [Internet] [Thesis]. Johns Hopkins University; 2013. [cited 2020 Sep 26]. Available from: http://jhir.library.jhu.edu/handle/1774.2/36974.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Biswas S. PERSISTENCE OF EBV IN THE CANCER STEM CELL FRACTION OF MULTIPLE MYELOMA. [Thesis]. Johns Hopkins University; 2013. Available from: http://jhir.library.jhu.edu/handle/1774.2/36974

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


Universidade Estadual de Campinas

24. Faria, Karina Morais, 1987-. Padrões radiográficos craniofaciais do mieloma múltiplo em pacientes tratados com bisfosfonatos = Craniofacial radiographic patterns of multiple myeloma in patients treated with bisphosphonates: Craniofacial radiographic patterns of multiple myeloma in patients treated with bisphosphonates.

Degree: 2016, Universidade Estadual de Campinas

 Abstract: This thesis evaluated the frequency and radiographic patterns of multiple myeloma (MM) in craniofacial bones through clinical, pathological and radiographic investigations in a retrospective… (more)

Subjects/Keywords: Mieloma múltiplo; Radiografia panorâmica; Difosfonatos; Multiple myeloma; Radiography, panoramic; Diphosphonates

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Faria, Karina Morais, 1. (2016). Padrões radiográficos craniofaciais do mieloma múltiplo em pacientes tratados com bisfosfonatos = Craniofacial radiographic patterns of multiple myeloma in patients treated with bisphosphonates: Craniofacial radiographic patterns of multiple myeloma in patients treated with bisphosphonates. (Thesis). Universidade Estadual de Campinas. Retrieved from http://repositorio.unicamp.br/jspui/handle/REPOSIP/321291

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Faria, Karina Morais, 1987-. “Padrões radiográficos craniofaciais do mieloma múltiplo em pacientes tratados com bisfosfonatos = Craniofacial radiographic patterns of multiple myeloma in patients treated with bisphosphonates: Craniofacial radiographic patterns of multiple myeloma in patients treated with bisphosphonates.” 2016. Thesis, Universidade Estadual de Campinas. Accessed September 26, 2020. http://repositorio.unicamp.br/jspui/handle/REPOSIP/321291.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Faria, Karina Morais, 1987-. “Padrões radiográficos craniofaciais do mieloma múltiplo em pacientes tratados com bisfosfonatos = Craniofacial radiographic patterns of multiple myeloma in patients treated with bisphosphonates: Craniofacial radiographic patterns of multiple myeloma in patients treated with bisphosphonates.” 2016. Web. 26 Sep 2020.

Vancouver:

Faria, Karina Morais 1. Padrões radiográficos craniofaciais do mieloma múltiplo em pacientes tratados com bisfosfonatos = Craniofacial radiographic patterns of multiple myeloma in patients treated with bisphosphonates: Craniofacial radiographic patterns of multiple myeloma in patients treated with bisphosphonates. [Internet] [Thesis]. Universidade Estadual de Campinas; 2016. [cited 2020 Sep 26]. Available from: http://repositorio.unicamp.br/jspui/handle/REPOSIP/321291.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Faria, Karina Morais 1. Padrões radiográficos craniofaciais do mieloma múltiplo em pacientes tratados com bisfosfonatos = Craniofacial radiographic patterns of multiple myeloma in patients treated with bisphosphonates: Craniofacial radiographic patterns of multiple myeloma in patients treated with bisphosphonates. [Thesis]. Universidade Estadual de Campinas; 2016. Available from: http://repositorio.unicamp.br/jspui/handle/REPOSIP/321291

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


University of Rochester

25. Garcia-Bates, Tatiana M. Regulation of normal and malignant B lineage cells by the peroxisome proliferator activated receptor gamma (PPARy) pathway.

Degree: PhD, 2009, University of Rochester

 Protective humoral immune responses depend on B lymphocyte clonal expansion and differentiation to generate plasma cells that produce high-affinity antibodies to fight infection. However, B… (more)

Subjects/Keywords: PPAR Gamma; B Lymphoma; Multiple Myeloma; B Lymphocytes; B Cell Differentiation

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Garcia-Bates, T. M. (2009). Regulation of normal and malignant B lineage cells by the peroxisome proliferator activated receptor gamma (PPARy) pathway. (Doctoral Dissertation). University of Rochester. Retrieved from http://hdl.handle.net/1802/8466

Chicago Manual of Style (16th Edition):

Garcia-Bates, Tatiana M. “Regulation of normal and malignant B lineage cells by the peroxisome proliferator activated receptor gamma (PPARy) pathway.” 2009. Doctoral Dissertation, University of Rochester. Accessed September 26, 2020. http://hdl.handle.net/1802/8466.

MLA Handbook (7th Edition):

Garcia-Bates, Tatiana M. “Regulation of normal and malignant B lineage cells by the peroxisome proliferator activated receptor gamma (PPARy) pathway.” 2009. Web. 26 Sep 2020.

Vancouver:

Garcia-Bates TM. Regulation of normal and malignant B lineage cells by the peroxisome proliferator activated receptor gamma (PPARy) pathway. [Internet] [Doctoral dissertation]. University of Rochester; 2009. [cited 2020 Sep 26]. Available from: http://hdl.handle.net/1802/8466.

Council of Science Editors:

Garcia-Bates TM. Regulation of normal and malignant B lineage cells by the peroxisome proliferator activated receptor gamma (PPARy) pathway. [Doctoral Dissertation]. University of Rochester; 2009. Available from: http://hdl.handle.net/1802/8466


Wright State University

26. Ye, Qinmao. Exosomes Released from Multiple Myeloma Cells Influence the Angiogenic Function of Endothelial Cells by Regulating MicroRNA-29b.

Degree: MS, Pharmacology and Toxicology, 2018, Wright State University

Multiple myeloma is a hematological malignancy characterized by clonal proliferation of plasma cells generally caused by chromosomal abnormalities. It occurs in the bone marrow, which… (more)

Subjects/Keywords: Biology; Biomedical Research; Pharmacology; Exosomes; MicroRNA; Multiple Myeloma; Endothelial cells; Angiogenesis

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Ye, Q. (2018). Exosomes Released from Multiple Myeloma Cells Influence the Angiogenic Function of Endothelial Cells by Regulating MicroRNA-29b. (Masters Thesis). Wright State University. Retrieved from http://rave.ohiolink.edu/etdc/view?acc_num=wright1532474227694747

Chicago Manual of Style (16th Edition):

Ye, Qinmao. “Exosomes Released from Multiple Myeloma Cells Influence the Angiogenic Function of Endothelial Cells by Regulating MicroRNA-29b.” 2018. Masters Thesis, Wright State University. Accessed September 26, 2020. http://rave.ohiolink.edu/etdc/view?acc_num=wright1532474227694747.

MLA Handbook (7th Edition):

Ye, Qinmao. “Exosomes Released from Multiple Myeloma Cells Influence the Angiogenic Function of Endothelial Cells by Regulating MicroRNA-29b.” 2018. Web. 26 Sep 2020.

Vancouver:

Ye Q. Exosomes Released from Multiple Myeloma Cells Influence the Angiogenic Function of Endothelial Cells by Regulating MicroRNA-29b. [Internet] [Masters thesis]. Wright State University; 2018. [cited 2020 Sep 26]. Available from: http://rave.ohiolink.edu/etdc/view?acc_num=wright1532474227694747.

Council of Science Editors:

Ye Q. Exosomes Released from Multiple Myeloma Cells Influence the Angiogenic Function of Endothelial Cells by Regulating MicroRNA-29b. [Masters Thesis]. Wright State University; 2018. Available from: http://rave.ohiolink.edu/etdc/view?acc_num=wright1532474227694747


University of Toronto

27. Chen, Yedan. Characterizing Acquired Proteasome Inhibitor Resistance in Human Multiple Myeloma Cell Lines.

Degree: 2017, University of Toronto

Proteasome inhibitors (PIs) are a mainstay treatment for multiple myeloma (MM). Unfortunately, cure is rare. Here, we attempted to define mechanisms for PI resistance. Two… (more)

Subjects/Keywords: drug resistance; multiple myeloma; mycoplasma; proteasome inhibitor; 0992

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Chen, Y. (2017). Characterizing Acquired Proteasome Inhibitor Resistance in Human Multiple Myeloma Cell Lines. (Masters Thesis). University of Toronto. Retrieved from http://hdl.handle.net/1807/77769

Chicago Manual of Style (16th Edition):

Chen, Yedan. “Characterizing Acquired Proteasome Inhibitor Resistance in Human Multiple Myeloma Cell Lines.” 2017. Masters Thesis, University of Toronto. Accessed September 26, 2020. http://hdl.handle.net/1807/77769.

MLA Handbook (7th Edition):

Chen, Yedan. “Characterizing Acquired Proteasome Inhibitor Resistance in Human Multiple Myeloma Cell Lines.” 2017. Web. 26 Sep 2020.

Vancouver:

Chen Y. Characterizing Acquired Proteasome Inhibitor Resistance in Human Multiple Myeloma Cell Lines. [Internet] [Masters thesis]. University of Toronto; 2017. [cited 2020 Sep 26]. Available from: http://hdl.handle.net/1807/77769.

Council of Science Editors:

Chen Y. Characterizing Acquired Proteasome Inhibitor Resistance in Human Multiple Myeloma Cell Lines. [Masters Thesis]. University of Toronto; 2017. Available from: http://hdl.handle.net/1807/77769

28. M.T. Palano. ROLE OF JAGGED IN MULTIPLE-MYELOMA-ASSOCIATED ANGIOGENESIS.

Degree: 2019, Università degli Studi di Milano

 Il mieloma multiplo è una neoplasia delle plasma cellule ancora incubabile, caratterizzata dall’accumulo di cellule tumorali nel midollo osseo. Durante la progressione dalla fase di… (more)

Subjects/Keywords: Multiple myeloma; Angiogenesis; Notch; Jagged; Settore MED/04 - Patologia Generale

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Palano, M. (2019). ROLE OF JAGGED IN MULTIPLE-MYELOMA-ASSOCIATED ANGIOGENESIS. (Thesis). Università degli Studi di Milano. Retrieved from http://hdl.handle.net/2434/609611

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Palano, M.T.. “ROLE OF JAGGED IN MULTIPLE-MYELOMA-ASSOCIATED ANGIOGENESIS.” 2019. Thesis, Università degli Studi di Milano. Accessed September 26, 2020. http://hdl.handle.net/2434/609611.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Palano, M.T.. “ROLE OF JAGGED IN MULTIPLE-MYELOMA-ASSOCIATED ANGIOGENESIS.” 2019. Web. 26 Sep 2020.

Vancouver:

Palano M. ROLE OF JAGGED IN MULTIPLE-MYELOMA-ASSOCIATED ANGIOGENESIS. [Internet] [Thesis]. Università degli Studi di Milano; 2019. [cited 2020 Sep 26]. Available from: http://hdl.handle.net/2434/609611.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Palano M. ROLE OF JAGGED IN MULTIPLE-MYELOMA-ASSOCIATED ANGIOGENESIS. [Thesis]. Università degli Studi di Milano; 2019. Available from: http://hdl.handle.net/2434/609611

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

29. L. Apicella. NOTCH PRODUCES A DEREGULATION OF CXCR4/SDF-1A CHEMOKINE SIGNALING IN MULTIPLE MYELOMA CELLS.

Degree: 2013, Università degli Studi di Milano

 Notch deregulation occurs in several solid and hematopoietic tumors. Recently, Notch receptor oncogenic role has been shown to be critical in multiple myeloma (MM) which… (more)

Subjects/Keywords: NOTCH; multiple myeloma; CXCR4; SDF1; Settore MED/04 - Patologia Generale

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Apicella, L. (2013). NOTCH PRODUCES A DEREGULATION OF CXCR4/SDF-1A CHEMOKINE SIGNALING IN MULTIPLE MYELOMA CELLS. (Thesis). Università degli Studi di Milano. Retrieved from http://hdl.handle.net/2434/217441

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Apicella, L.. “NOTCH PRODUCES A DEREGULATION OF CXCR4/SDF-1A CHEMOKINE SIGNALING IN MULTIPLE MYELOMA CELLS.” 2013. Thesis, Università degli Studi di Milano. Accessed September 26, 2020. http://hdl.handle.net/2434/217441.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Apicella, L.. “NOTCH PRODUCES A DEREGULATION OF CXCR4/SDF-1A CHEMOKINE SIGNALING IN MULTIPLE MYELOMA CELLS.” 2013. Web. 26 Sep 2020.

Vancouver:

Apicella L. NOTCH PRODUCES A DEREGULATION OF CXCR4/SDF-1A CHEMOKINE SIGNALING IN MULTIPLE MYELOMA CELLS. [Internet] [Thesis]. Università degli Studi di Milano; 2013. [cited 2020 Sep 26]. Available from: http://hdl.handle.net/2434/217441.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Apicella L. NOTCH PRODUCES A DEREGULATION OF CXCR4/SDF-1A CHEMOKINE SIGNALING IN MULTIPLE MYELOMA CELLS. [Thesis]. Università degli Studi di Milano; 2013. Available from: http://hdl.handle.net/2434/217441

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

30. M. D'Anca. IDENTIFICATION AND VALIDATION OF CRITICAL 1Q21 'ACHILLES HEEL' VULNERABILITIES OF MULTIPLE MYELOMA.

Degree: 2016, Università degli Studi di Milano

Multiple Myeloma (MM) is malignancy of terminally differentiated plasma cells characterized by a marked heterogeneity of genetic lesions and clinical course. Despite significant efforts towards… (more)

Subjects/Keywords: Multiple Myeloma, 1q21, ILF2; Settore MED/15 - Malattie del Sangue

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

D'Anca, M. (2016). IDENTIFICATION AND VALIDATION OF CRITICAL 1Q21 'ACHILLES HEEL' VULNERABILITIES OF MULTIPLE MYELOMA. (Thesis). Università degli Studi di Milano. Retrieved from http://hdl.handle.net/2434/362028

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

D'Anca, M.. “IDENTIFICATION AND VALIDATION OF CRITICAL 1Q21 'ACHILLES HEEL' VULNERABILITIES OF MULTIPLE MYELOMA.” 2016. Thesis, Università degli Studi di Milano. Accessed September 26, 2020. http://hdl.handle.net/2434/362028.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

D'Anca, M.. “IDENTIFICATION AND VALIDATION OF CRITICAL 1Q21 'ACHILLES HEEL' VULNERABILITIES OF MULTIPLE MYELOMA.” 2016. Web. 26 Sep 2020.

Vancouver:

D'Anca M. IDENTIFICATION AND VALIDATION OF CRITICAL 1Q21 'ACHILLES HEEL' VULNERABILITIES OF MULTIPLE MYELOMA. [Internet] [Thesis]. Università degli Studi di Milano; 2016. [cited 2020 Sep 26]. Available from: http://hdl.handle.net/2434/362028.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

D'Anca M. IDENTIFICATION AND VALIDATION OF CRITICAL 1Q21 'ACHILLES HEEL' VULNERABILITIES OF MULTIPLE MYELOMA. [Thesis]. Università degli Studi di Milano; 2016. Available from: http://hdl.handle.net/2434/362028

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

[1] [2] [3] [4] [5] [6] [7] [8] [9]

.